News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,024 Results
Type
Article (41129)
Company Profile (265)
Press Release (684616)
Multimedia
Podcasts (85)
Webinars (20)
Section
Business (204742)
Career Advice (2027)
Deals (35550)
Drug Delivery (120)
Drug Development (81445)
Employer Resources (173)
FDA (16464)
Job Trends (14962)
News (346599)
Policy (32746)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2584)
Accelerated approval (42)
Adcomms (25)
Allergies (160)
Alliances (49577)
ALS (192)
Alzheimer's disease (1737)
Antibody-drug conjugate (ADC) (364)
Approvals (16779)
Artificial intelligence (592)
Autoimmune disease (221)
Automation (50)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (174)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (684)
Cancer (5277)
Cardiovascular disease (442)
Career advice (1716)
Career pathing (39)
CAR-T (296)
CDC (53)
Celiac Disease (2)
Cell therapy (790)
Cervical cancer (41)
Clinical research (70185)
Collaboration (1874)
Company closure (4)
Compensation (1253)
Complete response letters (69)
COVID-19 (2723)
CRISPR (98)
C-suite (963)
Cystic fibrosis (147)
Data (7009)
Decentralized trials (3)
Denatured (26)
Depression (152)
Dermatology (57)
Diabetes (548)
Diagnostics (6818)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (290)
Drug pricing (192)
Drug shortages (29)
Duchenne muscular dystrophy (265)
Earnings (91036)
Editorial (59)
Employer branding (21)
Employer resources (152)
Events (118292)
Executive appointments (1026)
FDA (19857)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1601)
Gene editing (210)
Generative AI (51)
Gene therapy (650)
GLP-1 (1011)
Government (4691)
Grass and pollen (6)
Guidances (396)
Healthcare (18915)
HIV (73)
Huntington's disease (51)
IgA nephropathy (91)
Immunology and inflammation (270)
Immuno-oncology (79)
Indications (155)
Infectious disease (3035)
Inflammatory bowel disease (199)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (272)
Interviews (316)
IPO (16649)
IRA (50)
Job creations (3645)
Job search strategy (1429)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (552)
Leadership (34)
Legal (7951)
Liver cancer (97)
Longevity (28)
Lung cancer (710)
Lymphoma (405)
Machine learning (52)
Management (59)
Manufacturing (906)
MASH (176)
Medical device (13843)
Medtech (13920)
Mergers & acquisitions (20049)
Metabolic disorders (1402)
mRNA (172)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (378)
Neuropsychiatric disorders (95)
Neuroscience (3117)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4524)
Now hiring (73)
Obesity (660)
Opinion (274)
Ovarian cancer (183)
Pain (226)
Pancreatic cancer (252)
Parkinson's disease (335)
Partnered (33)
Patents (549)
Patient recruitment (581)
Peanut (60)
People (59199)
Pharmaceutical (60)
Pharmacy benefit managers (31)
Phase 1 (21877)
Phase 2 (30901)
Phase 3 (23013)
Pipeline (7023)
Policy (302)
Postmarket research (2564)
Preclinical (9271)
Press Release (64)
Prostate cancer (274)
Psychedelics (49)
Radiopharmaceuticals (302)
Rare diseases (982)
Real estate (5957)
Recruiting (70)
Regulatory (24930)
Reports (54)
Research institute (2403)
Resumes & cover letters (353)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (160)
Series A (266)
Series B (199)
Service/supplier (11)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3624)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (84)
The Weekly (57)
Vaccines (1052)
Venture capital (98)
Weight loss (417)
Women's health (108)
Worklife (19)
Date
Today (91)
Last 7 days (635)
Last 30 days (2739)
Last 365 days (29962)
2026 (7756)
2025 (30171)
2024 (35213)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (738)
Alabama (89)
Alaska (7)
Arizona (328)
Arkansas (13)
Asia (39441)
Australia (6448)
California (12200)
Canada (3493)
China (1216)
Colorado (519)
Connecticut (518)
Delaware (364)
Europe (85180)
Florida (1845)
Georgia (392)
Hawaii (3)
Idaho (62)
Illinois (954)
India (78)
Indiana (555)
Iowa (22)
Japan (483)
Kansas (129)
Kentucky (44)
Louisiana (38)
Maine (73)
Maryland (1479)
Massachusetts (8706)
Michigan (344)
Minnesota (672)
Mississippi (6)
Missouri (137)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (82)
New Jersey (3255)
New Mexico (28)
New York (3211)
North Carolina (1546)
North Dakota (8)
Northern California (6035)
Ohio (361)
Oklahoma (22)
Oregon (41)
Pennsylvania (2466)
Puerto Rico (25)
Rhode Island (50)
South America (1111)
South Carolina (75)
South Dakota (1)
Southern California (4788)
Tennessee (198)
Texas (1913)
United States (43194)
Utah (365)
Vermont (1)
Virginia (291)
Washington D.C. (80)
Washington State (979)
West Virginia (4)
Wisconsin (117)
Wyoming (2)
726,024 Results for "kurin inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Kurin, Inc. Reports Record Revenue for Q1 2024
Kurin, Inc., the inventor and manufacturer of Kurin® blood culture collection sets, announced record revenues for the first quarter of 2024, following a record 2023.
April 3, 2024
·
2 min read
Business
Kurin Announces Appointment of Chief Commercial Officer
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced Christine Arme as their Chief Commercial Officer.
May 30, 2024
·
2 min read
Business
Kurin, Inc. Reports Record Revenue for Q3 2023
Kurin, Inc., the inventor and manufacturer of Kurin® blood culture collection sets, announced record revenues for the third quarter of 2023.
October 5, 2023
·
2 min read
Biotech Beach
USPTO Rejects Patent Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that the US Patent and Trademark Office has rejected the relevant claims of the ‘483 patent that Magnolia Medical asserted against Kurin.
August 15, 2023
·
1 min read
Biotech Beach
Kurin Launches Kurin Jet, Redefining the Blood Culture Contamination Device Market
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced the full-scale launch of Kurin Jet, which has joined the Kurin Lock family.
July 12, 2023
·
2 min read
Biotech Beach
Kurin, Inc. Named 2023 Diverse Supplier of the Year by Vizient
Kurin, Inc. has been named the 2023 Diverse Supplier of the Year by Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company.
September 27, 2023
·
2 min read
Biotech Beach
Delaware Federal Court Issues a Stay Order in Patent Dispute between Magnolia Medical and Kurin, Inc.
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, provided an update on the ongoing patent infringement case brought against Kurin by Magnolia Medical.
August 10, 2023
·
2 min read
Business
Kurin, Inc. Reports Record Revenue for 2022
Kurin, Inc., the inventor and manufacturer of the Kurin ® blood culture collection sets announced record revenues for 2022.
January 26, 2023
·
1 min read
Policy
USPTO Agrees to Kurin’s Request to Review Validity of Magnolia Medical’s ‘483 Patent
Kurin, Inc. announced that the US Patent and Trademark Office has granted Kurin’s Ex Parte request to reexamine the validity of U.S. Patent No. 10,039,483 that is asserted by Magnolia Medical in ongoing patent litigation.
May 3, 2023
·
2 min read
Biotech Beach
Kurin Announces Kurin Jet, A Quantum Leap Forward in Devices Designed to Address Blood Culture Contamination
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced the limited commercial release of Kurin Jet™, a significant technological advance over Kurin’s own market-leading Kurin Lock®.
February 15, 2023
·
2 min read
1 of 72,603
Next
